Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia

被引:17
作者
Skoumas, Loannis [1 ]
Masoura, Constantina [1 ]
Pitsavos, Christos [1 ]
Tousoulis, Dimitris [1 ]
Papadimitriou, Larnbros [1 ]
Aznaouridis, Konstantinos [1 ]
Chrysohoou, Christina [1 ]
Giotsas, Nikolaos [1 ]
Toutouza, Marina [1 ]
Tentolounis, Costas [1 ]
Antonlades, Charalarnbos [1 ]
Stefanadis, Christodoulos [1 ]
机构
[1] Univ Athens, Sch Med, Hippokratio Hosp, Dept Cardiol 1, Athens 16675, Greece
关键词
heterozygous familial hypercholesterolemia; Familial combined hyperlipidemia; Lipids; Cardiovascular risk factors; Coronary artery disease;
D O I
10.1016/j.ijcard.2006.11.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Heterozygous familial hypercholesterolemia (hFH) and familial combined hyperlipidemia (FCH) have been associated with increased risk for coronary artery disease (CAD), but the impact of traditional risk factors to the incidence of CAD in these patients remains unknown. The present study evaluates the contribution of such risk factors to the development of CAD in these two dyslipidemic populations. Methods: This cross-sectional study enrolled a total 1306 subjects; 600 individuals with hFH (mean age 41 13 years, 261 males and 339 females), and 706 individuals with FCH (mean age 49 11 years, 463 males and 243 females). Blood samples were collected after 12 hours fasting period, and serum lipids were determined. Multivariate logistic regression models were used to estimate the odds ratios of CAD based on the type of hyperlipidemia, after adjustment for demographic characteristics and risk factors. Results: Subjects with FCH were older (P<0.001), and they had a significantly increased prevalence of hypertension, diabetes and metabolic syndrome (40 vs. 10%, 13 vs. 2% and 41 vs. 6% respectively, all P<0.001) compared to the hFH group. Total cholesterol, LDL-cholesterol, and apolipoprotein B levels were higher (all P<0.001) in hFH subjects. Although in multivariate analysis lipid abnormalities found in hFH were associated with increased risk of CAD (P<0.001) compared with lipid abnormalities of FCH, the overall prevalence of CAD was similar between the two groups (16.7 vs. 15.3%, P=NS). Conclusions: Despite the high atherogenic potential of altered lipid metabolism found in hFH, the prevalence of CAD is similarly increased in patients with hFH or FCFL This may be related to the clustering of non-lipid cardiovascular risk factors, such as diabetes mellitus, observed in patients with FCH. (C) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:178 / 183
页数:6
相关论文
共 25 条
  • [1] [Anonymous], 1991, BMJ, V303, P893
  • [2] ISCHEMIC DISEASE IN MEN AND WOMEN WITH FAMILIAL HYPERCHOLESTEROLEMIA AND XANTHOMATOSIS - COMPARATIVE-STUDY OF GENETIC AND ENVIRONMENTAL-FACTORS IN 274 HETEROZYGOUS CASES
    BEAUMONT, V
    JACOTOT, B
    BEAUMONT, JL
    [J]. ATHEROSCLEROSIS, 1976, 24 (03) : 441 - 450
  • [3] Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk
    Carr, MC
    Brunzell, JD
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2601 - 2607
  • [4] Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population:: Influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol
    Chaves, FJ
    Real, JT
    García-García, AB
    Civera, M
    Armengod, ME
    Ascaso, JF
    Carmena, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (10) : 4926 - 4932
  • [5] Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia
    Civeira, F
    [J]. ATHEROSCLEROSIS, 2004, 173 (01) : 55 - 68
  • [6] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [7] FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations
    Dedoussis, GVZ
    Skoumas, J
    Pitsavos, C
    Choumerianou, DM
    Genschel, J
    Schmidt, H
    Stefanadis, C
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 (06) : 402 - 409
  • [8] Familial combined hyperlipidemia and insulin resistance - Distant relatives linked by intra-abdominal fat?
    Eckel, RH
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 469 - 470
  • [9] CORONARY-ARTERY DISEASE IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS WITH THE SAME LDL RECEPTOR GENE MUTATION
    FERRIERES, J
    LAMBERT, J
    LUSSIERCACAN, S
    DAVIGNON, J
    [J]. CIRCULATION, 1995, 92 (03) : 290 - 295
  • [10] GENETIC AND ENVIRONMENTAL-FACTORS AFFECTING THE INCIDENCE OF CORONARY-ARTERY DISEASE IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    HILL, JS
    HAYDEN, MR
    FROHLICH, J
    PRITCHARD, PH
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02): : 290 - 297